Phosphoinositide-3-OH kinases (PI(3)Ks) constitute a family of evolutionari
ly conserved lipid kinases that regulate a vast array of fundamental cellul
ar responses, including proliferation, transformation, differentiation and
protection from apoptosis(1,2). PI(3)K-mediated activation of the cell surv
ival kinase PKB/Akt, and negative regulation of PI(3)K signalling by the tu
mour suppressor PTEN (refs 3, 4) are key regulatory events in tumorigenesis
(5-7). Thus, a model has arisen that PI(3)K gamma promote development of ca
ncers. Here we report that genetic inactivation of the p110 gamma catalytic
subunit of PI(3)K gamma (ref. 8) leads to development of invasive colorect
al adenocarcinomas in mice. In humans, p110 gamma protein expression is los
t in primary colorectal adenocarcinomas from patients and in colon cancer c
ell lines. Overexpression of wild-type or kinase-dead p110 gamma in human c
olon cancer cells with mutations of the tumour suppressors APC and p53, or
the oncogenes beta-catenin and Ki-ras, suppressed tumorigenesis. Thus, loss
of p110 gamma in mice leads to spontaneous, malignant epithelial tumours i
n the colorectum and p110 gamma can block the growth of human colon cancer
cells.